Trial intelligence / Profile preview

Food intake and micronutrient status effects on praziquantel in schistosomiasis-infected schoolchildren

ISRCTN19261544Phase 4Recruiting

Sponsor
Centre Suisse de Recherches Scientifiques en Côte d'Ivoire
Start
Jul 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of praziquantel in schistosomiasis, sponsored by Centre Suisse de Recherches Scientifiques en Côte d'Ivoire. Started Jul 2026; status: recruiting.

02

Drugs

praziquantel
03

Conditions

schistosomiasis

Beyond the preview

Go deeper on ISRCTN19261544.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN19261544.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call